Welcome to InteReg!
from Andreas Walther (left), Claire Jacob and Ari Waisman (right)
Photo © Dominik Gruszczyk
InteReg is an interdisciplinary research consortium, whose mission is to develop therapeutic solutions based on interactive biomaterials to treat neurodegenerative diseases such as multiple sclerosis and traumatic injuries such as brain and spinal cord injuries. InteReg is funded by the Carl Zeiss Stiftung (CZS Press release). JGU Press release in German and English
InteReg unites world-renown experts in the fields of Neurobiology, Neuroimmunology, Chemistry and Polymer Research (Link to our Team) to bridge Neuroregeneration and Soft Biomaterials, two Strongholds of research in Mainz, and make significant impacts in the development of Neuroregenerative Interactive Biomaterials.
About the Carl-Zeiss-Stiftung
The Carl-Zeiss-Stiftung’s mission is to create an open environment for scientific breakthroughs. As a partner of excellence in science, it supports basic research as well as applied sciences in the STEM subject areas (science, technology, engineering and mathematics). Founded in 1889 by the physicist and mathematician Ernst Abbe, the Carl-Zeiss-Stiftung is one of the oldest and biggest private science funding institutions in Germany. It is the sole owner of Carl Zeiss AG and SCHOTT AG. Its projects are financed from the dividend distributions of the two foundation companies.